Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E

NCT00761501 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: PN400
DRUG: Naproxen (Proxen S)
DRUG: Naproxen (Naprosyn E)

Sponsor

AstraZeneca